According to the latest report by Polaris Market Research, the global Coronary Stent Market size was valued at USD 13.48 billion in 2025 and is projected to reach USD 25.80 billion by 2034, registering a CAGR of 7.5% between 2026 and 2034. Growth is being driven by the rising prevalence of cardiovascular diseases and continued advancements in stent technology.

Coronary Stent Market at a Glance

Understanding the Coronary Stent Market

A coronary stent is a small, expandable mesh tube inserted into narrowed or blocked coronary arteries to restore normal blood flow to the heart muscle, primarily in patients with coronary artery disease. Deployed via a balloon catheter during angioplasty, stents keep the artery open, with drug-eluting variants releasing medication to limit scar tissue formation and reduce the risk of re-narrowing. The market covers the production and distribution of these devices and continues to expand alongside rising cardiovascular disease prevalence and growing demand for minimally invasive treatment options.

What Are the Major Factors Influencing the Market?

Coronary stent demand is being shaped by disease burden, device innovation, and evolving treatment preferences.

Key Growth Driver: Increasing Prevalence of Cardiovascular Diseases

Cardiovascular diseases, particularly coronary artery disease, remain the leading cause of death globally, with the World Health Organization attributing approximately 17.9 million deaths annually to the category. This high disease burden drives continued reliance on coronary stents for effective treatment, with the growing prevalence of cardiovascular conditions among aging populations reinforcing sustained demand for stent implantation procedures.

Emerging Opportunity: Rising Demand for Minimally Invasive Procedures

Patients and healthcare providers increasingly favor minimally invasive techniques for their shorter recovery times, reduced hospital stays, and lower overall costs. Coronary stenting, as a less invasive alternative to coronary artery bypass grafting, aligns closely with this shift, supported by advanced imaging and catheter-based interventions that are expected to offer lucrative growth opportunities for stent-based treatments.

Market Trend: Advancements in Stent Technology

Continued innovation in stent design and materials is a defining trend, with drug-eluting stents improving patient outcomes by reducing restenosis, and bioresorbable stents, designed to dissolve after fulfilling their purpose, gaining traction for their potential to lower long-term complications. Ongoing research is focused on improving flexibility, reducing thrombosis risk, and enabling better vascular healing.

Key Challenge: High Cost of Products

The high cost of advanced stent products, particularly drug-eluting and bioresorbable variants, can hinder broader market adoption, especially in cost-sensitive healthcare systems and emerging markets where affordability remains a key barrier to treatment access.

𝐄𝐱𝐩𝐥𝐨𝐫𝐞 𝐓𝐡𝐞 𝐂𝐨𝐦𝐩𝐥𝐞𝐭𝐞 𝐂𝐨𝐦𝐩𝐫𝐞𝐡𝐞𝐧𝐬𝐢𝐯𝐞 𝐑𝐞𝐩𝐨𝐫𝐭 𝐇𝐞𝐫𝐞 :

https://www.polarismarketresearch.com/industry-analysis/coronary-stent-market 

How Is AI Impacting the Coronary Stent Market?

AI Impact Assessment

Artificial intelligence is already playing a tangible role in the coronary stent industry. AI improves coronary angiography analysis, enabling faster and more accurate detection of artery blockages and helping physicians select the right stent type and placement strategy. Machine learning is supporting personalized stent selection based on lesion complexity, vessel size, and patient risk profile, contributing to improved treatment outcomes. Predictive analytics is helping identify high-risk coronary artery disease patients earlier, increasing demand for preventive interventions and coronary stenting. On the manufacturing side, smart, AI-enhanced production is improving quality control, reducing production costs, and supporting faster innovation in stent technologies.

Which Market Segments Are Gaining Momentum?

By type, the market is segmented into bare-metal stents (BMS), drug-eluting stents (DES), and bioabsorbable stents. DES held the largest share at 68.0% in 2025, owing to superior efficacy in reducing restenosis rates through the gradual release of anti-proliferative drugs, supported by strong clinical evidence for both elective and emergency procedures. Bioabsorbable stents, while still a smaller segment, are registering the fastest growth within this axis on the strength of their innovative, dissolving design, though the source report does not disclose a specific numeric growth rate for the segment.

By mode of delivery, balloon-expandable stents held the largest share at 71.0% in 2025, valued for precise deployment in controlled, elective procedures. Self-expanding stents are the fastest-growing delivery format, at an 8.3% CAGR, favored for their adaptability in complex, tortuous, or calcified arteries and growing use in peripheral artery disease and high-risk patients.

By end user, hospitals accounted for the largest share at 59.0% in 2025, supported by high procedure volumes and comprehensive diagnostic, therapeutic, and post-operative capabilities. Cardiac centers are registering the fastest growth in this segment, driven by their specialized focus on cardiovascular care, though the source report does not disclose a specific numeric growth rate for this segment either.

What Is Happening Across Regional Markets?

North America held the largest share of the global coronary stent market at 38.0% in 2025, driven by a high prevalence of cardiovascular diseases, advanced healthcare infrastructure, early adoption of innovative stent technologies, and favorable reimbursement policies, with the U.S. contributing significantly through a rising number of percutaneous coronary intervention procedures. Europe is growing at a 7.0% CAGR, supported by well-established healthcare infrastructure and rising cardiovascular disease prevalence, with Germany, France, and the UK as key contributors. Asia Pacific is the fastest-growing region, expanding at a 9.3% CAGR, driven by rising heart disease incidence, an expanding healthcare sector, and growing healthcare expenditure across China, India, and Japan. Latin America and the Middle East & Africa are included in the report's regional scope, though the source data does not disclose specific share or growth figures for these regions.

How Is the Competitive Landscape Changing?

The competitive landscape of the coronary stent market is shaped by continuous research and development, product innovation, and strategic partnerships. Key players are focused on developing next-generation stents, including bioresorbable scaffolds and drug-eluting stents with enhanced safety profiles, while expanding global reach and strengthening distribution networks. Abbott Laboratories is known for its XIENCE series of drug-eluting stents, Medtronic offers the Resolute Integrity and Resolute Onyx stents, Boston Scientific's SYNERGY stent features a bioabsorbable polymer coating, Terumo Corporation provides the Ultimaster stent, and Biotronik's Orsiro stent has drawn attention for its ultrathin strut design. Collaborations with healthcare providers and participation in clinical trials continue to shape competitive positioning across the industry.

Key players operating in the Coronary Stent market include:

• Abbott Laboratories
• Medtronic
• Boston Scientific Corporation
• Terumo Corporation
• B. Braun Melsungen AG
• C. R. Bard, Inc. (a subsidiary of Becton, Dickinson and Company)
• Cook Medical Inc.
• Biotronik SE & Co. KG
• MicroPort Scientific Corporation
• Biosensors International Group, Ltd.
• Stentys SA
• Lepu Medical Technology (Beijing) Co., Ltd.
• Meril Life Sciences Pvt. Ltd.
• SMT (Sahajanand Medical Technologies)
• REVA Medical, Inc.

Future Market Perspective

The coronary stent market is positioned for steady growth through 2034, underpinned by rising cardiovascular disease prevalence, an aging global population, and continued preference for minimally invasive treatment. Ongoing development of bioresorbable stents, drug-eluting technologies with enhanced safety profiles, and expansion into high-growth Asia Pacific markets are expected to shape competitive dynamics. Companies that combine clinical innovation, cost efficiency, and expanding emerging-market reach are best positioned to capture the market's long-term growth trajectory.

More Trending Latest Reports By Polaris Market Research:

top-5-companies-transforming-electric-vehicle-ev-parts-and-components-market-in-2025

bearings-market

understanding-the-role-of-ignition-coils-in-modern-automotive-combustion

brain-machine-interface-market

natural-stone-market

customer-experience-management-market

artificial-intelligence-in-manufacturing-market

types-of-market-research

loitering-munition-market